Dipeptiven® is safe in a rat model of moderate liver dysfunction

by Melanie K. Bothe, Rosa Abele, Heinrich Topp, Johannes Harleman, Martin Westphal, John F. Stover
Published 2018-10-01

Missing evidence for toxicity of high PFAT5 levels in mixtures of lipids

by Melanie K. Bothe, Lida A. Quinchia, Getachew Assegehegn, Crispulo Gallegos-Montes, Edmundo Brito de la Fuente, Johannes Harleman
Published 2016-08-01

A peripherally restricted P2Y12 receptor antagonist altered rat tumor incidences with no human relevance: Mode of action consistent with dopamine agonism

by David A. Brott, Håkan A.S. Andersson, Jane Stewart, Lorna Ewart, Greg Christoph, Johannes Harleman, Duncan Armstrong, Lewis B. Kinter
Published 2014-01-01

Dipeptiven® improves kidney pathology in a rat model of chronic kidney disease

by Melanie K. Bothe, Dirk Berressem, Rosa Abele, Heinrich Topp, Birgit Alteheld, Peter Stehle, Johannes Harleman, Martin Westphal, John F. Stover
Published 2019-06-01